Characterization of an Envelope Mutant of HIV-1 That Interferes with Viral Infectivity  by Chen, Steve S.-L. et al.
VIROLOGY 226, 260–268 (1996)
ARTICLE NO. 0654
Characterization of an Envelope Mutant of HIV-1 That Interferes with Viral Infectivity
STEVE S.-L. CHEN,*,† ANTHONY A. FERRANTE,* and ERNEST F. TERWILLIGER*,1
*Division of Hematology/Oncology, Deaconess Hospital and Harvard Medical School, Boston, Massachusetts 02215; and
†Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China
Received April 16, 1996; returned to author for revision May 21, 1996; accepted October 15, 1996
A mutant human immunodeficiency virus (HIV-1) provirus encoding an envelope (Env) protein with a truncated transmem-
brane protein cytoplasmic domain was defective for replication. Coexpression of the mutant with a wild-type (wt) HIV-1
provirus potently inhibited the production of infectious virus. The maximum inhibitory effect was reached when the ratio of
mutant to wt proviral DNA was 2:1. This transdominant defect in infectivity conferred by the mutant Env did not appear to
involve the late steps of virus replication, since the synthesis, precursor processing, and intracellular transport of the Env
proteins were not blocked; nor did it prevent the incorporation of the envelope proteins into virions or the subsequent
release of the virus. Although the mutant Env protein still retained syncytia-forming ability, the truncated protein was unable
to mediate cell-to-cell transmission of the virus. Moreover, coexpression with the mutant effectively inhibited the ability of
the wt Env to mediate cell-to-cell transmission. The mutant Env protein formed a complex with the wt protein when they
were coexpressed, producing heterooligomeric structures which appeared to be severely defective in an early, post-CD4
binding step of the virus life cycle despite the inclusion of wt Env in the complexes. q 1996 Academic Press, Inc.
INTRODUCTION teins of HIV-2 and SIV when they are coexpressed, sug-
gesting that higher-ordered structures, rather than pri-
Mutant viral proteins can sometimes inhibit the biologi-
mary sequences, are involved in Env oligomerization
cal function of the corresponding wt protein in a trans-
(Doms et al., 1990). Recently, electron microscopy, muta-dominant fashion. In the case of human immunodefi-
genesis, and fusion protein expression studies haveciency virus type-1 (HIV-1), certain gag mutants have
shown that the structural determinants that are importantbeen shown to interfere with wild-type (wt) virus assem-
for HIV-1 Env oligomerization are located in the extracel-bly (Trono et al., 1989). Transdominant mutants of HIV-1
lular domain of gp41 (Earl et al., 1990; Thomas et al.,Tat (Green et al., 1989) and Rev (Malim et al., 1989) which
1991; Earl and Moss, 1993; Bernstein et al., 1995; Poum-can inhibit the steps of HIV-1 transactivation and viral
bourios et al., 1995).RNA processing driven by their respective wt proteins
As oligomeric structures, Env proteins represent suit-have also been described. The use of such mutant viral
able candidates for the generation of transdominant mu-proteins has been proposed as a novel strategy to com-
tants which could interfere with wt function by formingbat HIV-1 infection.
defective complexes with the wt Env. In this regard, FreedThe envelope (Env) precursor proteins of HIV-1, human
and colleagues reported that a polar substitution of Gluimmunodeficiency virus type-2 (HIV-2), and simian immu-
for Val at amino acid 2 of the hydrophobic membranenodeficiency virus (SIV) assemble as oligomeric struc-
fusion domain of the HIV-1 gp41 inhibits wt Env protein-tures in the rough endoplasmic reticulum (RER) (Gelder-
mediated syncytia formation and virus infectivity (Freedblom et al., 1988; Grief et al., 1989; Pinter et al., 1989;
et al., 1992). Mutations at other residues in this region,Rey et al., 1989, 1990; Doms et al., 1990; Earl et al., 1990;
or in the V3 loop or in the precursor cleavage site, didThomas et al., 1991). After acquiring defined secondary
not seem to confer interfering effects on wt protein func-and tertiary structures in the RER, the Env proteins are
tion. A transdominant Env mutant containing an in-frametransported to the Golgi complex and from there targeted
deletion in the putative CD4-binding site of the HIV-2 Envto the cell surface, where virus assembly and budding
protein has also been isolated (Steffy and Wong-Staal,take place. During its transit through the Golgi, the HIV-
1993). While it was proposed in these cases that the1 Env precursor (gp160) undergoes cleavage into two
mutants formed defective heterooligomers with the cor-products, the exterior glycoprotein (gp120) and the trans-
membrane protein (gp41). The Env proteins of HIV-1 can responding wt proteins, direct evidence for such struc-
form heterooligomers with the corresponding Env pro- tures and their consequent effects on the virus life cycle
was not possible.
In this study, we demonstrate that coexpression of a1 To whom reprint requests should be addressed at Hematology/Oncol-
wt HIV-1 provirus together with a mutant encoding aogy Research Laboratories, Deaconess Hospital, 21-27 Burlington Street,
Boston, MA 02215. Fax: (617) 859-7010. E-mail: eterwiligr@aol.com. truncated gp41 transdominantly interferes with viral repli-
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cation. Expression of the mutant Env protein effectively frameshift mutation from HXV-m into pSVE7 and pBSX,
respectively.inhibits cell-to-cell virus transmission mediated by the
wt protein. We confirm the formation of dysfunctional
heterooligomers between the mutant and wt Env pro- Transfection of plasmid DNA into cells
teins, to which the interference effect conferred by the
The 293 cells were transfected either with proviralmutant is attributed.
DNA or with Env expression plasmids and pIIIextat, in
the presence of 0.1 mM chloroquine for 6 hr at 377 by
MATERIALS AND METHODS calcium phosphate coprecipitation. Subconfluent COS-1
cells (5 1 106) were trypsinized and transfected with 10Cells and antibodies
mg of plasmid DNA using DEAE–dextran as described
COS-1 and 293 cells were cultured in Dulbecco’s modi- previously (Chen et al., 1993).
fied Eagle’s medium (DMEM) supplemented with 10%
heat-inactivated fetal calf serum (FCS). SupT1 and H9, Western blot (immunoblot) analysis
two human CD4-positive T-lymphoid cell lines, were
Two days after transfection, 293 cells were lysed withpropagated in RPMI 1640 containing 10% FCS.
0.2 ml of phosphate-buffered saline (PBS) containing 1%HIV-1 patient antisera were kindly provided by Dr. Ken-
Nonidet-P40, 1% sodium deoxycholate, and 1 mM phenyl-neth McIntosh of Children’s Hospital (Boston, MA). Sheep
methylsulfonyl fluoride. To obtain virions, culture mediumanti-gp120 (strain IIIB), the Chessie 8 hybridoma, a mu-
from cells transfected with provirus was centrifuged atrine monoclonal antibody (MAb) reactive with an epitope
1200 rpm for 5 min. Supernatants were spun at 2000 rpmaround amino acid residue 728 in gp160, and rabbit anti-
for 30 min and then virions were isolated by centrifuga-p25/p24 (strain SF2) were all obtained from the AIDS
tion at 27,000 rpm for 2 hr through a 20% sucrose cushionResearch and Reference Program, NIH.
(Go¨ttlinger et al., 1993). Aliquots of cell or virion lysates
were analyzed by Western blot as described previouslyPlasmids
(Chen, 1994).
HXV-m, derived from HXB2, an infectious clone of HIV-
1 (Fisher et al., 1985), has a single G base deleted from Reverse transcriptase (RT) and virus infection assay
the GTT codon at position 8315 in the env gene. This
Two days posttransfection, culture medium was col-deletion results in a shift of the open reading frame at
lected and spun at 2000 rpm for 5 min, and the culturethis position and a predicted premature termination of
supernatants were filtered through 0.45-mm membranesthe nascent Env protein after the leucine at position 703
to remove cell debris. Virions were pelleted by polyethyl-in the transmembrane region of gp41. The region of env
ene glycol and RT activities were determined as de-containing this deletion does not overlap other cis or
scribed previously (Chen et al., 1993). To examine virustrans sequences known to be critical for virus replication
infectivity, SupT1 or H9 cells were infected with 105 RTsuch as the coding regions of Tat and Rev, or the Rev-
units of virus, and RT activity was monitored on succes-responsive element (RRE).
sive days postinfection.pSVE7, also known as pSVIIIenv (Sodroski et al., 1986),
contains the SV40 origin of replication and expresses
Heterooligomerization studythe Env protein of HXB2 under the control of the HIV-1
long terminal repeat (LTR). This vector also expresses a Cells transfected with Env expression vectors were
functional Rev protein. Cotransfection with pIIIextat (Ro- lysed and incubated with either anti-HIV-1 or Chessie 8
sen et al., 1986), a Tat protein expression vector, was MAb-coated protein A–Sepharose beads. The immune
used to transactivate expression of Env from pSVE7. complexes were washed in PBS plus 1% Triton X-100,
Plasmid pHXBCATDBgl, also known as pHXBDenvCAT and the proteins were released from the beads by boiling
(Terwilliger et al., 1989; Helseth et al., 1990), contains a samples in Laemmli gel loading buffer. Proteins were
defective HXB2 provirus incorporating an in-frame dele- analyzed on a Western blot.
tion between the two BglII sites at positions 7041 and
7621 in the env gene as well as a substitution of the CAT assay
chloramphenicol acetyltransferase (CAT) gene for nef
gene sequences. pHXBgagCAT encodes a severely dys- CAT activity was determined 3 days posttransfection
as described previously (Terwilliger et al., 1989; Helsethfunctional provirus mutant in which sequences encom-
passing the principal splice donor, as well as the gag et al., 1990). The reaction products were resolved by thin-
layer chromatography using Kodak Chromogen silicasequences, have been deleted and substituted with the
CAT sequence. Plasmid BABY, an SV40 late replacement plates and visualized by autoradiography. The relative
signals of acetylated and native chloramphenicol wereexpression vector (Rekosh et al., 1988), was used to gen-
erate pBSX for the expression of HXB2env. Plasmids determined using a PhosphoImager (Molecular Dynam-
ics, Inc., Sunnyvale, CA).pSVE7-TC and pBSX-TC were generated by cloning the
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protein presumably contained the truncated sequence of
gp41 encoded by HXV-m. Consistent with this, no full-
length gp41 was detected in the lysates from cells ex-
pressing the HXV-m products (Fig. 1, lane 3). However,
a smaller molecular weight protein, denoted as gp41-tc,
was found in the HXV-m lysate (Fig. 1, lane 3), which
was not seen with HXB2. This species likely represents
the truncated transmembrane protein of HXV-m derived
from the cleavage of the gp160-tc precursor. This was
further supported by the observation that no Env species
were recognized in lysates prepared from HXV-m-trans-
fected cultures by the Chessie 8 MAb, which is specific
for gp41 at an epitope around amino acid residue 728
and is predicted to be missing from the HXV-m Env (data
not shown).
Interference with wt virus infectivity by cotransfection
with the HXV-m provirus
Recent studies regarding a role for the HIV-1 gp41
FIG. 1. Viral protein expression in 293 cells transfected with HXB2 cytoplasmic domain in virus infectivity have produced
or HXV-m. 293 cells grown in 100-mm petri dishes were transfected
conflicting findings. Several investigators have claimedwith 10 mg of either HXB2 or HXV-m proviral DNA using a standard
an important role for the cytoplasmic domain in viruscalcium phosphate coprecipitation protocol. Mock-transfected cells
were included as a negative control. Two days after transfection, ly- infection (Gabuzda et al., 1992; Dubay et al., 1992; Yu et
sates of cells and virions were prepared as described under Materials al., 1993). However, Wilk et al. reported that a deletion
and Methods. Equivalent portions of the cell lysates were separated of 144 amino acids, including most of the cytoplasmic
by 10% SDS–PAGE and then visualized by Western blot analysis using
domain, from the C-terminus of gp41 did not affect eitherAIDS patient sera.
virus infectivity or cytopathogenicity in MT-4 cells (Wilk
et al., 1992). In the case of HXV-m, no signs of productive
RESULTS infection could be detected following challenge of two
different CD4-positive human T-cell lines, SupT1 and H9,
Analysis of viral protein expression in cells
with virus derived from 293 cells transfected with the
transfected with HXV-m
HXV-m provirus, even at long times postchallenge (data
not shown). This indicated that the HXV-m virus has aBased upon the sequence of its mutant env gene, the
gp41 encoded by the HXV-m provirus was predicted to severe defect in the virus replication cycle.
The mutation in the Env transmembrane protein en-be missing the entire cytoplasmic domain as well as two
amino acids in the transmembrane region of the protein coded by HXV-m would not be expected to interfere with
the production of virions from other transfected proviruscompared to the wt. To examine the viral proteins synthe-
sized by HXV-m, 293 cells were transfected with either plasmids. To examine whether HXV-m would interfere
with the production of infectious wt virus, virus stocksHXV-m or the wt HXB2 provirus plasmids. The 293 cells
are highly transfectable, but lack the CD4 molecule on were generated from 293 cells transfected with HXB2,
with HXV-m, or with HXB2 and HXV-m together in differ-their surface. Therefore, virus produced by the trans-
fected cells accumulates in the supernatant but cannot ent molar ratios. In each case, the amount of HXB2 DNA
was held constant and pHXBgagCAT, a grossly defectivereinfect the culture. Equivalent amounts of cell lysate
from 293 cells transfected with either provirus were ana- provirus with a deletion encompassing the gag as well
as principal splice donor sequences, was added to eachlyzed by SDS–PAGE and visualized using AIDS patient
sera. As shown in Fig. 1, similar levels of viral proteins, transfection to maintain a constant final concentration of
DNA. Transfection with HXV-m alone or with HXB2 plusincluding gp120, were produced by the HXB2 and HXV-
m proviruses. The viral proteins other than the Env pre- HXV-m at a 1:1 DNA ratio resulted in similar levels of
virion-associated RT activity as that produced by trans-cursor synthesized by HXV-m appeared to be normal,
judging by the migration mobilities and quantities of fection with HXB2, confirming that HXV-m was not defec-
tive at the level of virus protein production, virion assem-these proteins compared with those produced by HXB2.
In contrast, the Env precursor encoded by HXV-m, de- bly, or release into the culture medium (data not shown).
SupT1 cells were then challenged with equivalentnoted as gp160-tc, migrated faster than the HXB2 gp160
precursor (compare Fig. 1, lanes 2 and 3). Since this amounts of virus from each transfected culture. As shown
in Fig. 2, the virus from cells transfected with HXV-mspecies had an apparent molecular weight of approxi-
mately 140 kDa, larger than that of wt gp120, this Env alone was not infectious. When virus from cells trans-
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comparable levels of virion-associated and cell-associ-
ated gp120. This demonstrated that coexpression with
the mutant protein did not block Env assembly into viri-
ons. These results further indicated that coexpression
with the mutant protein did not affect wt Env protein
synthesis nor block wt Env precursor cleavage.
Syncytia induction by the coexpressed Env proteins
To achieve better insight into the nature of the interfer-
ence with wt virus infectivity caused by the HXV-m Env
products, vectors were constructed so that the mutant
Env proteins could be expressed in the absence of the
rest of the viral proteins. Two existing Env plasmid vec-
tors expressing the HXB2 strain of Env, pSVE7 and pBSX,
FIG. 2. Effect of cotransfection of HXV-m with the HXB2 provirus on were modified for this purpose. A 2.1-kb KpnI–BamHI
the production of infectious virus. 293 cells were transfected with 5 mg
fragment of HXV-m, encompassing the mutation in envof HXB2 or HXV-m, or 5 mg of HXB2 plus various amounts of HXV-m
(from nucleotides 6351 to 8475 in the HXB2 sequence),DNA as indicated in the figure. The total amount of DNA in all transfec-
tions was kept constant at 30 mg by supplementing with plasmid was substituted for the corresponding sequences in
HXBgagCAT. Culture supernatants were collected, centrifuged, and pSVE7 and pBSX to yield plasmids pSVE7-TC and pBSX-
filtered 2 days after transfection. 105 cpm of RT activity from each stock TC, respectively.
was then used to challenge 2 1 106 SupT1 cells, and the cultures were
To determine whether the mutant HXV-m Env protein,monitored for virus production at regular intervals postinfection.
expressed alone or coexpressed with the wt protein, was
still capable of inducing syncytia formation in CD4-posi-
fected with both HXB2 and HXV-m was used, there was tive cells, 293 cells transfected with pSVE7, with pSVE7-
a significant delay in the appearance of RT activity, which TC, or with pSVE7 plus pSVE7-TC at a 1:1 DNA ratio
lengthened with increasing amounts of HXV-m in the were cocultivated 2 days posttransfection with SupT1
provirus mix. This inhibition of virus replication conferred cells. Cultures were examined for syncytia 18 hr after
by HXV-m reached a maximum level when the DNA ratio co-cultivation. As shown in Fig. 4A, no syncytia were
of HXV-m to HXB2 was 2:1. The degree of the inhibitory observed in the mock-transfected cells. However, ex-
effect was not markedly enhanced when the DNA ratio pression of either the wt or mutant Env proteins resulted
of HXV-m to HXB2 was increased further to 5:1 or higher in extensive syncytia formation (Figs. 4B and 4C). No
(data not shown). As the amount of the wt HXB2 plasmid differences in the size or extent of syncytia formation
was held constant in all of the transfections, these obser- were noted between the wt and the mutant Env proteins.
vations indicated that the presence of HXV-m exerted Moreover, the coexpressed Env proteins resulted in syn-
an inhibitory effect on the production of infectious virus. cytia formation to an extent similar to that induced by
Challenge of fresh SupT1 cells with the virus which even- the wt and mutant proteins individually (Fig. 4D). Taken
tually emerged from cultures receiving the mixed trans- together, these studies confirmed that coexpression of
fections resulted in productive infections indistinguish- the mutant protein with the wt Env did not block intracel-
able from those receiving HXB2 alone. lular transport of the Env protein nor inhibit the ability of
the surface-associated Env protein to mediate mem-
Assembly of gp120 into virions after cotransfection brane fusion.
with wt and mutant proviral DNAs
Interference with wt Env protein-mediated virus
To examine whether or not the defect in infectivity of transmission by the mutant
the mutant as well as the mixed mutant/wt viruses could
be due to a lack of gp120 association with virions, 293 A trans-complementation assay (Helseth et al., 1990)
was performed to confirm that, despite the findings fromcells were transfected with HXB2, with HXV-m, or with
HXB2 and HXV-m at a 1:1 DNA ratio. Equivalent aliquots the syncytia formation assays, Env protein-mediated
transmission of the HXV-m virus was blocked and to testof cell and virion lysates from each transfection were
then analyzed by Western blotting successively using whether the presence of the truncated HXV-m Env was
sufficient to account for the defective phenotype ob-goat anti-gp120 and rabbit anti-p25/p24, and the immune
complexes were visualized by horseradish peroxidase served with that virus as well as that of the mixed wt
and mutant proviruses. This assay assesses the abilityactivity detected by ECL (Amersham Corp., Arlington
Heights, IL). As shown in Fig. 3, similar levels of virion- of Env proteins provided in trans to complement an Env-
defective provirus, SVCATDBgl, for a single round of rep-associated p24 resulted following the HXB2 and HXV-m
cotransfection as well as from transfections with HXB2 lication. SVCATDBgl contains a large deletion in the env
gene sequences, as well as a substitution of the CATor HXV-m alone. Moreover, all transfections produced
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FIG. 3. Incorporation of gp120 into wt or mutant virions. 293 cells were transfected with 10 mg of either HXB2 or HXV-m proviral DNA, or with 5
mg each of HXB2 and HXV-m DNA by the calcium phosphate coprecipitation method. Two days after transfection, virions in the supernatants were
isolated as described under Materials and Methods. Equivalent portions of cell and viral lysates were separated by 7.5% SDS–PAGE, followed by
Western blot analysis successively using goat anti-gp120 and rabbit anti-p25/p24. The immune complexes were visualized by horseradish peroxidase
detected by chemiluminescence.
gene for nef sequences as a convenient indicator for lysates either with AIDS patient antisera or with the Ches-
sie 8 MAb, whose epitope is missing in gp160-tc. Theviral gene expression. SVCATDBgl was cotransfected
with the Env expression vectors pBSX, pBSX-TC, or pBSX immune complexes were then washed and eluted from
the beads, and the proteins were separated by SDS–and pBSX-TC together at different molar ratios. Three
days posttransfection, lysates prepared from the trans- PAGE. The blot was then analyzed with anti-gp120 to
detect the Env species that were precipitated by the firstfected cells were measured for CAT activity. As shown
in Fig. 5, wt Env successfully mediated cell-to-cell virus antibodies. As expected, gp160-tc was precipitated by
patient antisera but not by the Chessie 8 MAb from cellstransmission as evidenced by markedly increased CAT
activity compared with the Env-minus control. In contrast, transfected with pBSX-TC alone (Fig. 6, lanes 3 and 7).
In contrast, gp160-tc was readily precipitated by thethe Env proteins derived from HXV-m mediated cell-to-
cell transmission only poorly (Fig. 5, lane 3). Most impor- Chessie 8 MAb when it was coexpressed with the wt
Env protein (Fig. 6, lane 8), demonstrating that the trun-tantly, the mutant Env expressed from pBSX-TC trans-
dominantly interfered with cell-to-cell transmission when cated Env protein indeed forms a complex with gp160.
cotransfected with pBSX in a dose-dependent manner.
This result confirmed that the mutant Env protein per se DISCUSSION
interferes with wt virus infectivity.
The cytoplasmic domain of HIV-1 gp41 has been re-
ported as having varying degrees of influence upon virusHeterooligomerization between the wt and the mutant
replication, infectivity, and cytopathogenicity (Fisher etEnv proteins
al., 1986; Terwilliger et al., 1986; Lee et al., 1989). Dele-
tions within this region can significantly reduce viral in-As the mutant Env protein contained the complete ec-
todomain of gp41, it presumably still possessed the abil- fectivity and transmissibility (Kowalski et al., 1987;
Helseth et al., 1990; Dubay et al., 1992; Gabuzda et al.,ity to form oligomers. To examine whether the wt and
mutant proteins were physically associated with each 1992; Yu et al., 1993). These studies indicate that the
cytoplasmic domain of gp41 has multiple roles in theother when they were coexpressed, COS-1 cells were
transfected with pBSX, pBSX-TC, or pBSX and pBSX-TC virus life cycle and suggest that this region can be a
target for an anti-HIV strategy.in a 1:1 ratio. Env proteins were precipitated from cell
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FIG. 4. Syncytia-forming ability of the HXV-m Env proteins. 293 cells were cotransfected with 3 mg of pIIIextat and 20 mg of either pSVE7 or
pSVE7-TC, or with 10 mg each of pSVE7 and pSVE7-TC as indicated. One day posttransfection, cells were trypsinized and 1.5 1 106 cells were
seeded onto 35-mm petri dishes. Two days posttransfection, 1.5 1 106 SupT1 cells were added to the cultures. Cell co-cultures were then examined
by photomicroscopy the following day. (A, B, C, and D) Co-cultures in which the 293 cells received either a mock transfection, or pSVE7, pSVE7-
TC, or pSVE7 and pSVE7-TC together, respectively.
In a previously reported Env mutant study, the forma- tion with either mutant or wt provirus plasmids. Further-
more, the defect in viruses bearing the mutant Env fromtion of mixed oligomers was suggested to account for a
transdominant interference with wt virus infectivity (Freed HXV-m does not appear to result from a lack of incorpora-
tion of the Env protein into the virions nor from impairedet al., 1992; Steffy and Wong-Staal, 1993). However, the
molecular events underlying the interference were ob- virus release into the medium (Fig. 3). This is in good
agreement with the observations of other investigatorsscure. In the present study, we demonstrate that an HIV-
1 Env protein lacking a complete gp41 cytoplasmic do- who have found that deletions in the cytoplasmic domain
do not affect Env incorporation into virions (Gabuzda etmain is not only fundamentally defective, but can inter-
fere with the replication of an infectious wt virus through al., 1992; Freed et al., 1995; Mammano et al., 1995). This
finding is also consistent with the defective phenotypethe formation of defective heterooligomers with the wt
Env protein. The presence of these heterooligomers ap- of the hybrid viruses derived following cotransfection of
the wt and mutant proviruses. If the defect in HXV-mpears to confer upon viruses bearing them the same
grossly defective phenotype observed with viruses bear- were due to lack of incorporation of the mutant Env onto
virions, then viruses derived from these cotransfections,ing only the mutant Env species.
The impaired infectivity and replication of viruses bear- bearing only wt Env, should not be defective.
Being oligomeric, wt and mutant Env proteins maying either homo- or heterooligomers of the mutant Env
does not seem to involve the late steps of the virus repli- combine to form a variety of complexes with different
wt-to-mutant ratios. Heterooligomers containing mutantcation cycle. The maturation processes of the mutant
Env are not affected when compared with the wt (Figs. subunits presumably are dysfunctional. Nevertheless,
among these mixed populations there is presumably a1, 3, and 6), and CD4-negative cell lines such as 293
produce equivalent quantities of virus following transfec- homooligomeric species constituted by the wt protein
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only. The presence of this species likely accounts for the
eventual RT production in SupT1 cells challenged with
the mix of viruses derived from the HXB2/HXV-m cotrans-
fections (Fig. 2). This is also consistent with the finding
that the virus which eventually grows out of these cul-
tures exhibits a wt phenotype.
The defect in replication of viruses bearing the mutant
HXV-m Env does not seem to be attributable to a failure
of the Env protein to bind CD4, since the truncated mutant
protein is still able to mediate syncytia formation with
CD4-positive cells (Fig. 4). This observation is in good
agreement with earlier studies which reported that trun-
cations in gp41 do not affect CD4 binding (Kowalski et
al., 1987; Earl et al., 1991), nor do they alter the syncytia-
forming ability of the Env protein (Kowalski et al., 1987;
Helseth et al., 1990; Earl et al., 1991; Dubay et al., 1992).
However, the mutant Env protein cannot efficiently medi-
ate cell-to-cell virus transmission, as shown by the re-
sults of the trans-complementation assay (Fig. 5). FIG. 6. Heterooligomerization between wt and mutant Env proteins.
Taken together, these studies suggest that viruses in- COS-1 cells were transfected with 10 mg of pBABY, pBSX, pBSX-TC,
or 5 mg each of pBSX and pBSX-TC. Two days posttransfection, cellscorporating the mutant Env protein bear a defect in the
were lysed and precipitated with protein A–Sepharose beads coatedearly phase of the virus life cycle in the steps subsequent
with either AIDS patient sera (lanes 1–4) or Chessie 8 MAb (lanes 5–to receptor binding and membrane fusion. While it is
8). Proteins eluted from the beads were separated by SDS–PAGE and
uncertain why a heterooligomeric Env multimer incorpo- then analyzed by Western blotting using anti-gp120.
rating a subunit lacking the intracytoplasmic domain
should render the whole complex inactive in virus infec-
tion, precedents have been described. It was previously tion was also blocked by coexpression with a mutant
shown that the expression of a truncated form of the receptor lacking most of the cytoplasmic domain (Ueno
fibroblast growth factor (FGF) receptor, containing only et al., 1991).
the extracellular and transmembrane domains, effec- The processes which occur immediately following fu-
tively inhibited wt FGF receptor-mediated mesoderm for- sion between the viral and cellular membranes, including
mation in Xenopus embryos (Amaya et al., 1991). Platelet- dismantling of the capsid and the formation of an active
derived growth factor receptor-mediated signal transduc- preintegration complex containing the viral RNA, remain
poorly understood (Bukrinsky et al., 1993a; Bukrinsky et
al., 1993b).
Recently, several lines of evidence have shown that
the cytoplasmic domain of gp41 has a specific interaction
with the viral matrix protein (MA). Alterations to MA im-
pair the incorporation of the Env protein into nascent
HIV-1 virions (Yu et al., 1992; Dorfman et al., 1994). This
block in Env incorporation imposed by mutations in MA
can in turn be overcome by deletions of the cytoplasmic
domain (Freed et al., 1995; Mammano et al., 1995). The
cytoplasmic domain of gp41 also contains a signal that
directs the polarized budding of virions in MDCK cells
(Lodge et al., 1994). It is likely that the specific associa-
tion between the oligomeric gp41 cytoplasmic domain
and MA may not only promote efficient Env assembly
into virions, but play a role in viral uncoating, and that
the transdominant defect in HXV-m lies here. Further
studies will be required to address this question.
FIG. 5. Cell-to-cell transmission of a defective provirus mediated by
wt or mutant Env proteins. 107 SupT1 cells were transfected with 5 mg ACKNOWLEDGMENTS
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